Velayutham, N. K., Thamaraikani, T., Wahab, S., Khalid, M., Gobinath, R., Abullais, S. S., . . . Jeyabalan, S. (2024). Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers Media.
Chicago Style (17th ed.) CitationVelayutham, Naveen Kumar, et al. Corrigendum: Stylopine: A Potential Natural Metabolite to Block Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) in Osteosarcoma Therapy. Frontiers Media, 2024.
MLA (9th ed.) CitationVelayutham, Naveen Kumar, et al. Corrigendum: Stylopine: A Potential Natural Metabolite to Block Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) in Osteosarcoma Therapy. Frontiers Media, 2024.
Warning: These citations may not always be 100% accurate.